|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
FY2021
12 months to Jun 30, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Installation and maintenance | |||||
| Housekeeping | |||||
| Senior care services | |||||
| Educational consulting services | |||||
| Sales of pharmaceutical products | |||||
| Total revenues | |||||
| Cost of revenues | |||||
| Installation and maintenance | |||||
| Housekeeping | |||||
| Senior care services | |||||
| Educational consulting services | |||||
| Sales of pharmaceutical products | |||||
| Total cost of revenues | |||||
| Gross profit | |||||
| Operating expenses | |||||
| Sales and marketing expenses | |||||
| General and administrative expenses | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expenses), net | |||||
| Interest income | |||||
| Interest expense | |||||
| Accretion of financing cost | |||||
| Fair value loss | |||||
| Other income (expenses), net | |||||
| Total other expenses, net | |||||
| Total other income (expenses), net | |||||
| Loss before income taxes from continuing operations | |||||
| Income tax expense | |||||
| Net loss from continuing operations | |||||
| Discontinued operations: | |||||
| Loss from discontinued operations, net of income taxes | |||||
| Gain on disposal of discontinued operations, net of tax | |||||
| Net income (loss) from discontinued operations | |||||
| Net loss | |||||
| Other comprehensive loss | |||||
| Foreign currency translation adjustment, net of tax | |||||
| Total comprehensive loss | |||||
| Net loss per ordinary share - basic (in Dollars per share) | |||||
| Net loss per ordinary share - diluted (in Dollars per share) | |||||
| Weighted average number of ordinary shares outstanding - basic (in Shares) | |||||
| Weighted average number of ordinary shares outstanding - diluted (in Shares) | |||||
| Net loss attributable to shareholders | |||||
| Net (loss) income attributable to shareholders | |||||
| Net loss attributable to non-controlling interests | |||||
Loading...